OSEL Devices Ltd Q4 FY26 Share Price & Earnings Call Analysis

Financials of OSEL Devices Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of OSEL Devices Ltd

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of OSEL Devices Ltd

Profit & Loss

Annual income statement trend

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +576582132186246
Expenses +556173110153201
Operating Profit349223345
OPM %5%7%11%17%18%18%
Other Income +000000
Interest011336
Depreciation111111
Profit before tax237192938
Tax %33%29%33%32%31%
Net Profit +125132027
EPS in Rs9.9911.3925.0410.9912.4316.04
Dividend Payout %0%0%0%0%0%

Financials of OSEL Devices Ltd

Balance Sheet

Capital structure and asset base

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital122121618
Reserves46101492159
Borrowings +109182550100
Other Liabilities +81719484046
Total Liabilities23334999198323
Fixed Assets +657181722
CWIP000000
Investments0000041
Other Assets +17284280180259
Total Assets23334999198323

Financials of OSEL Devices Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +-33-1113-38
Cash from Investing Activity +00-2-13-0
Cash from Financing Activity +5-28453
Net Cash Flow21-4414
Free Cash Flow-32-120-38
CFO/OP-106%72%-113%67%-97%

Financials of OSEL Devices Ltd

Ratios

Working capital efficiency and return ratios

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days45635773128
Inventory Days28639491104
Days Payable37948413077
Cash Conversion Cycle36336735156
Working Capital Days-12-72738163
ROCE %26%35%54%31%

Others in Healthcare Equipment & Supplies this season

  • QMS Medical (Q1 FY27)

    Contract renewals historically exhibit a 60-70% roll-over rate annually, ensuring revenue visibility from existing clients. Key concall takeaways from QMS…

  • Laxmi Dental (Q1 FY27)

    PAT grew 23.8% y-o-y in Q1 FY27, showing healthy bottom-line growth (Page 4). Key concall takeaways from Laxmi Dental Ltd's Q1 FY27 earnings call — and how it…

  • Tarsons Products (Q2 FY26)

    Plastic labware market is expanding faster than glass, currently at INR1,200 crores, signaling long-term sector growth opportunities. Key concall takeaways…

  • Vaidya Sane (Q2 FY26)

    Ongoing construction and CAPEX of about INR 25-30 crores for capacity expansion at Khopoli and Nagpur hospitals. Key concall takeaways from Vaidya Sane's Q2…

Compare:vs Poly Medicurevs Molbio Diagnostivs Fischer Medical